Entegris
ENTG
$144.72
-7.49%
Entegris Inc. is a leading supplier of purification solutions and advanced materials, with the vast majority of its sales directed to the semiconductor industry. The company operates as a critical enabler across the entire semiconductor manufacturing supply chain, specializing in materials science and purity, which are foundational to advanced chip fabrication. The current investor narrative is heavily focused on the company's role as a beneficiary of the secular growth in semiconductor manufacturing, particularly driven by AI infrastructure build-out and the transition to more complex process nodes that demand higher purity materials. Recent financial trends, however, show a debate around near-term cyclical pressures, as evidenced by a recent quarterly revenue decline, juxtaposed against a powerful stock price rally that suggests the market is pricing in a strong recovery and long-term structural demand.…
ENTG
Entegris
$144.72
Investment Opinion: Should I buy ENTG Today?
Rating & Thesis: Hold. Entegris is a high-quality company in a critical industry niche, but its stock price has run far ahead of its current fundamentals, embedding overly optimistic recovery expectations and creating a poor risk/reward profile at current levels. The mixed analyst sentiment, with recent upgrades countered by a downgrade and a Sell rating, reflects this uncertainty.
Supporting Evidence: The recommendation is supported by four key data points. First, valuation is extreme, with a forward P/E of 35.2x implying a major earnings rebound. Second, fundamentals are weak, with Q4 revenue declining -3.1% YoY. Third, profitability is under severe pressure, with gross margin down 720 bps. Fourth, while free cash flow remains strong at $570.7M, the stock's technical overextension (trading at 98% of its 52-week high after a +95.7% year) suggests near-term exhaustion.
Risks & Conditions: The two biggest risks are a failure of margins to recover, invalidating the earnings growth story, and a broad derating of semiconductor multiples. This Hold rating would upgrade to a Buy if the forward P/E compresses below 25x on sustained price weakness without a deterioration in the long-term story, or if Q1 2026 results show clear sequential margin expansion. It would downgrade to a Sell if revenue growth fails to turn positive in the next two quarters or if gross margins fall below 35%. The stock is currently overvalued relative to its near-term fundamentals but may be fairly valued if the anticipated sharp earnings recovery materializes on schedule.
Sign up to view all
ENTG 12-Month Price Forecast
The outlook for ENTG is one of high uncertainty balanced by strong long-term positioning. The base case of consolidation is most likely, as the market digests the stock's massive rally and awaits confirmation of the fundamental recovery already priced in. The key to the stance is the margin recovery; visibility into this will drive the next major move. The neutral stance would upgrade to bullish on evidence of sustained margin expansion (gross margin >41% for two consecutive quarters) and downgrade to bearish if revenue growth remains negative into Q3 2026. Investors should prepare for volatility given the stock's 1.32 beta.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Entegris's 12-month outlook, with a consensus price target around $188.14 and implied upside of +30.0% versus the current price.
Average Target
$188.14
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$116 - $188
Analyst target range
Analyst coverage for Entegris appears limited in the provided dataset, with only 2 analysts cited for EPS estimates, which is insufficient to derive a robust consensus recommendation or target price. The estimated EPS range for these analysts is between $5.54 and $5.90, with an average of $5.75, implying forward-looking fundamentals. The lack of a clear consensus target price and the minimal analyst count typically indicates this may be a mid-cap stock with specialized coverage, or the data provided is incomplete. Recent institutional rating actions show a generally positive bias among the firms that do cover it; since January 2026, there have been several reiterations of Buy/Overweight ratings from Citigroup, Needham, Keybanc, and BMO Capital, and one upgrade from UBS (from Neutral to Buy). However, there was also a downgrade from Seaport Global (from Buy to Neutral) and a maintained Sell rating from Goldman Sachs. This mix of opinions, coupled with the wide target price range that likely exists (though not specified in the data), signals moderate uncertainty and debate regarding the near-term trajectory and the appropriate valuation for the stock amidst its powerful rally.
Bulls vs Bears: ENTG Investment Factors
The investment debate for Entegris centers on the tension between powerful long-term secular growth drivers and severe near-term cyclical pressures. The bull case, currently supported by stronger technical and sentiment evidence, is built on the stock's explosive momentum, the company's critical role in semiconductor purity, and expectations for a sharp earnings rebound. The bear case is grounded in concrete financial deterioration: declining revenue, collapsing margins, and an extreme valuation that prices in a flawless recovery. The single most important factor that will resolve this debate is the timing and magnitude of the margin recovery. If gross margins can sustainably rebound toward historical levels above 45%, the bull thesis will be validated. If margin pressure persists into the next earnings cycle, the elevated valuation will be untenable, triggering a significant correction.
Bullish
- Powerful Technical Uptrend: The stock has gained 95.7% over the past year and 70.4% over the past six months, with a recent 1-month surge of 26.6% significantly outperforming the S&P 500 (+8.7%). This momentum, with the stock at 98% of its 52-week high, signals strong market conviction in a recovery narrative. The price action suggests the market is aggressively pricing in a cyclical rebound and long-term structural demand.
- Strong Free Cash Flow Generation: Despite recent earnings pressure, the company generated $570.7 million in TTM free cash flow, providing a robust financial foundation. This strong cash generation supports internal funding for growth, debt management, and strategic initiatives without external dependency. The healthy current ratio of 3.35 further underscores a solid liquidity position.
- Critical Role in Semiconductor Purity: Entegris operates as a critical enabler in the semiconductor supply chain, specializing in high-purity materials essential for advanced chip fabrication. This positions the company as a direct beneficiary of secular trends like AI infrastructure build-out and the transition to more complex process nodes. Its niche expertise creates high switching costs and a durable competitive moat.
- Analyst EPS Growth Expectations: Analysts expect a significant earnings recovery, with forward EPS estimates averaging $5.75, implying 54% growth from the trailing EPS figure. This expectation is reflected in the valuation gap between a trailing P/E of 54.2x and a forward P/E of 35.2x. The market is clearly pricing in a sharp rebound in profitability.
Bearish
- Cyclical Revenue Decline & Margin Compression: Q4 2025 revenue declined 3.1% YoY to $823.9M, continuing a sequential downtrend. More critically, gross margin contracted sharply to 38.4% from 45.6% a year ago, and net margin halved to 6.0% from 12.0%. This indicates the company is facing significant near-term cyclical headwinds and pricing/mix pressure, contradicting the stock's parabolic rise.
- Extreme Valuation Premium: The stock trades at a forward P/E of 35.2x and a trailing P/E of 54.2x, which is historically elevated and likely at a premium to sector peers. The current trailing P/E is near the top of its historical range (21.0x to 119.4x), indicating the market has priced in a near-perfect recovery. This leaves no margin for error and high vulnerability to multiple compression.
- Parabolic Price Move & Overextension Risk: Trading at 98% of its 52-week high after a 95.7% annual gain, the stock shows signs of a parabolic advance. With a beta of 1.32, it is 32% more volatile than the market, and such vertical rallies often precede periods of consolidation or sharp correction. The technical setup suggests the risk/reward is skewed negatively in the near term.
- Limited Analyst Coverage & Mixed Sentiment: Only 2 analysts are cited for EPS estimates, indicating limited coverage and potentially less robust consensus. Furthermore, recent rating actions include a downgrade (Seaport Global: Buy to Neutral) and a maintained Sell (Goldman Sachs), highlighting ongoing debate and uncertainty about the near-term trajectory and appropriate valuation.
ENTG Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 1-year price change of +95.68% and a 6-month gain of +70.43%. As of the latest close at $155.98, the price is trading near the top of its 52-week range, approximately 98% of the way from the 52-week low of $66.32 to the high of $159.15, indicating significant momentum but also potential overextension and vulnerability to a pullback. Recent short-term momentum is exceptionally strong and accelerating, with a 1-month surge of +26.63% and a 3-month gain of +35.98%, far outpacing the broader market's 1-month return of +8.7% for SPY, as highlighted by a relative strength of +17.93 points over that period. This recent explosive move builds upon the longer-term uptrend, suggesting the stock is in a parabolic phase, though such vertical rallies often precede periods of consolidation or correction. Key technical levels are clear, with immediate resistance at the 52-week high of $159.15 and major support at the 52-week low of $66.32, though more relevant near-term support likely resides around the $130-$135 zone where the stock consolidated in February. A decisive breakout above $159.15 would signal a continuation of the bullish trend, while a breakdown below recent support could trigger a deeper correction. The stock's beta of 1.318 indicates it is approximately 32% more volatile than the broader market, which investors must factor into position sizing and risk management given its recent extreme moves.
Beta
1.32
1.32x market volatility
Max Drawdown
-36.0%
Largest decline past year
52-Week Range
$66-$159
Price range past year
Annual Return
+81.2%
Cumulative gain past year
| Period | ENTG Return | S&P 500 |
|---|---|---|
| 1m | +27.4% | +12.2% |
| 3m | +20.0% | +2.3% |
| 6m | +65.4% | +4.7% |
| 1y | +81.2% | +29.2% |
| ytd | +61.6% | +4.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ENTG Fundamental Analysis
Revenue growth has recently stalled, with Q4 2025 revenue of $823.9 million representing a year-over-year decline of -3.05%, continuing a trend of sequential quarterly revenue decreases from $849.8 million in Q4 2024. The business is segmented, with Advanced Purity Solutions contributing $464.5 million and Materials Solutions contributing $361.8 million in the latest period, though the lack of growth rates for these segments limits a detailed driver analysis; the overall trend suggests cyclical headwinds in the semiconductor equipment and materials sector. The company remains profitable but with compressed margins; Q4 2025 net income was $49.4 million, yielding a net margin of 6.0%, a significant contraction from the 12.0% net margin in Q4 2024. Gross margin for the quarter was 38.35%, down from 45.57% a year ago, indicating pressure on pricing or product mix, while operating margin stood at 14.40%. The balance sheet and cash flow position remains healthy, with a strong current ratio of 3.35 and a manageable debt-to-equity ratio of 0.98. The company generated substantial free cash flow over the trailing twelve months, reported at $570.7 million, providing ample liquidity to fund operations and growth internally. Return on equity (ROE) for the period was 5.96%, which is modest but reflects the impact of lower profitability in the recent quarter.
Quarterly Revenue
$823900000.0B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$570700000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ENTG Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is elevated at 54.25x, while the forward P/E is 35.21x, based on estimated EPS of $5.75. The significant gap between trailing and forward multiples implies the market expects a substantial earnings recovery, pricing in an estimated 54% growth in EPS from the trailing figure. Compared to sector averages, the stock trades at a premium; its forward P/E of 35.2x is well above typical semiconductor materials and equipment peers, though a direct industry average P/E is not provided in the data. This premium is likely justified by the market's perception of Entegris's critical, high-margin niche in semiconductor purity and its leverage to long-term industry growth drivers like AI and advanced packaging. Historically, the stock's own valuation has expanded dramatically; its current trailing P/E of 54.2x is near the top of its observable range over the past several years, where it has traded as low as 21.0x (Q2 2023) and as high as 119.4x (Q4 2023). Trading near historical highs suggests the market is pricing in very optimistic expectations for a sharp earnings rebound, leaving little room for disappointment.
PE
54.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -42x~119x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Entegris faces significant financial risks from its recent margin compression and earnings volatility. Gross margin contracted 720 basis points YoY to 38.4% in Q4 2025, while net income fell 52% to $49.4 million, squeezing the net margin to 6.0%. This earnings pressure increases the company's dependence on a swift cyclical recovery to justify its premium valuation. While the balance sheet is healthy with a debt-to-equity of 0.98 and strong free cash flow of $570.7M, the core risk is that the margin deterioration is structural rather than cyclical, which would permanently impair profitability and investor returns.
Market & Competitive Risks: The primary market risk is valuation compression. Trading at a forward P/E of 35.2x, the stock carries a significant premium that is vulnerable if growth expectations are not met. Its beta of 1.318 means it is 32% more volatile than the market, amplifying downside moves during sector-wide sell-offs. Competitive risks, while mitigated by its niche expertise, include potential pricing pressure from customers and innovation from rivals in materials science. The stock's parabolic 95.7% annual gain also introduces sector rotation risk, as investors may take profits in high-flying semiconductor names at the first sign of broader market weakness.
Worst-Case Scenario: The worst-case scenario involves a prolonged semiconductor downturn combined with failed margin recovery, leading to consecutive earnings misses. This would trigger multiple compression from the current elevated P/E toward its historical low of 21x, compounded by downward EPS revisions. A realistic downside could see the stock re-test its 52-week low of $66.32, representing a potential loss of approximately -57% from the current price of $155.98. A more immediate, severe correction could target the $110-$120 support zone (a -25% to -30% decline) if the next quarterly report disappoints, given the stock's high volatility and extended technical position.
FAQ
The key risks are, in order of severity: 1) Valuation & Execution Risk: The high P/E multiple leaves the stock vulnerable to a sharp decline if the expected earnings recovery is delayed or falls short. 2) Cyclical & Margin Risk: The company's fortunes are tied to the volatile semiconductor capex cycle, and the recent 720 bps gross margin contraction may not be fully cyclical. 3) Technical Risk: After a 95.7% annual gain, the stock is technically overextended and prone to a significant correction, amplified by its high beta of 1.32. 4) Concentration Risk: Nearly all revenue is derived from the semiconductor industry, lacking diversification.
The 12-month forecast is bifurcated, with a high degree of uncertainty. The base case (55% probability) sees the stock consolidating between $140 and $160 as the company shows gradual fundamental improvement. The bull case (25% probability), targeting $175-$195, requires a strong cyclical rebound and margin recovery. The bear case (20% probability) could see a correction to $100-$120 if earnings disappoint. The most likely scenario is the base case, predicated on the assumption that revenue growth turns modestly positive and margins stabilize, allowing the elevated valuation to slowly digest the recent massive gains.
Based on current fundamentals, ENTG appears overvalued. The forward P/E of 35.2x is historically elevated for the stock and likely at a premium to its semiconductor materials peers, implying the market expects EPS to grow 54% from trailing levels. This valuation is difficult to justify when revenue is declining and margins are under severe pressure, with Q4 gross margin at 38.4% versus 45.6% a year ago. The valuation is fair only if the company delivers on the anticipated sharp earnings rebound in the coming quarters. Currently, the market is paying a premium price for future growth that has yet to materialize in the financial statements.
At the current price of $155.98, ENTG presents a challenging risk/reward profile, making it not a compelling buy for most investors. The stock has already priced in a robust earnings recovery, trading at a forward P/E of 35.2x while fundamentals are still weak, with Q4 revenue down -3.1% and margins compressed. For aggressive growth investors with a high risk tolerance and a long-term view (3+ years), any significant pullback towards the $130-$140 support zone could offer a better entry point to capitalize on the long-term semiconductor growth story. However, for conservative or valuation-sensitive investors, the current level carries too much risk of multiple compression.
ENTG is primarily suitable for long-term investors with a minimum 2-3 year horizon. Its business is leveraged to multi-year secular trends in semiconductor technology, but it is also highly cyclical, leading to significant short-term volatility (beta 1.32). Short-term traders face high risk due to the stock's parabolic move and extended valuation, which could lead to sharp pullbacks on any negative news. Long-term investors can better weather the industry cycles and benefit from the company's critical role in chip manufacturing. The minimal dividend yield of 0.48% indicates it is not an income stock, further reinforcing its suitability for growth-oriented, long-term portfolios.